Aspartate aminotransferase (AST) =< 3 x ULN
Aspartate aminotransferase (AST) =< 3.0 X ULN, within 14 days of registration
Aspartate aminotransferase (AST) and/or ALT ? 2.5 × ULN
Aspartate aminotransferase (AST) < 5 times ULN
Aspartate aminotransferase (AST [SGOT]) ?2.5 × the ULN;
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 2 x ULN OR if hepatic involvement by lymphoma: AST =< 5 x ULN
aspartate aminotransferase (AST) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases
Aspartate aminotransferase (AST) =< 1.5 x institutional ULN
Aspartate aminotransferase (AST) =< 3 X ULN
INCLUSION - TREATMENT: Aspartate aminotransferase (AST) ? 5x
Within 14 days of the first dose of study drug: Aspartate aminotransferase (AST) =< 3 x ULN
Aspartate aminotransferase (AST) level =< 2.5 × ULN.
Aspartate aminotransferase (AST) < 3 x ULN unless due to the underlying leukemia approved by the PI
Aspartate aminotransferase (AST) ? 3.0 x ULN (unless considered due to leukemic organ involvement)
Aspartate aminotransferase (AST) greater than 2.0 times the ULN in the absence of known hepatic metastases
Aspartate aminotransferase (AST) > 45 U/L
Aspartate aminotransferase (AST) =< 3 x ULN.
Aspartate aminotransferase (AST) level =< 2.5 x ULN
Serum aspartate aminotransferase (AST) ?3 × ULN (Grade ?1).
Aspartate aminotransferase (AST) < 3 x ULN unless considered due to leukemic involvement
Aspartate aminotransferase (AST) ? 1.5 x ULN
aspartate aminotransferase (AST) <= 3.0 x ULN*
Aspartate aminotransferase (AST) =< 2.5 x ULN
To be performed within 14 days prior to day 1 of protocol therapy: aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 3 x ULN.
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN within 14 days of study registration.
Aspartate aminotransferase (AST) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN (=< 5 x ULN for subjects with documented metastatic disease to the liver).
Aspartate aminotransferase (AST) within 2.5 x ULN unless there are liver metastases in which case, AST within 5 x ULN
Aspartate aminotransferase (AST) =< 3 x ULN.
Aspartate aminotransferase (AST) =< 2.0 x ULN
Aspartate aminotransferase (AST) within 2.5 x ULN unless there are liver metastases in which case, AST within 5 x ULN
Aspartate aminotransferase (AST) =< 5 x ULN
Aspartate aminotransferase (AST) =< 3 x ULN
Obtained within 14 days of randomization: Aspartate aminotransferase (AST) =< 3 x ULN
aspartate aminotransferase (AST) ? 3.0 × ULN*
Aspartate aminotransferase (AST) =< 2.5 x ULN prior to biopsy
Aspartate transaminase (aspartate aminotransferase [AST]) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN (obtained within 28 days prior to first study treatment)\r\n* Subjects with documented liver metastases should have AST =< 5 x ULN
LYMPHODEPLETION: Aspartate aminotransferase (AST) =< 3.0 x ULN, obtained within 72 hrs prior to procurement
Aspartate aminotransferase (AST) and AST <3x institutional ULN within 7 days prior to starting the study drug.
Aspartate aminotransferase (AST) =< 1.5 x ULN for the laboratory
Aspartate aminotransferase (AST) < 3 x ULN
Aspartate aminotransferase (AST) =< 1.5 x ULN
Aspartate aminotransferase (AST) =< 2 x ULN for the laboratory
Aspartate transaminase (aspartate aminotransferase [AST]) > 3.0 x ULN
Aspartate aminotransferase (AST) =< 2.5 X ULN
Aspartate aminotransferase (AST) < 2.5 x ULN (3 x ULN for subjects on chronic anticonvulsive therapies known to increase transaminases).
PRIOR TO CELL PROCUREMENT: Aspartate aminotransferase (AST) ? 3 times ULN
Aspartate aminotransferase (AST) =< 3 x ULN for the laboratory, except in the presence of known hepatic metastasis, wherein the AST may be =< 5 x ULN
Aspartate aminotransferase =< 3 x ULN
Within 3 months of registration: Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 3 times the ULN
Within 14 days prior to study entry: Aspartate aminotransferase (AST) =< 3 x ULN
Any serum aspartate aminotransferase (AST) is allowed but serum AST =< 34 IU/L is strongly encouraged
Aspartate aminotransferase (AST) =< 2.5 x ULN for the laboratory
Aspartate aminotransferase (AST) =< 3.5 x ULN
TREATMENT: Aspartate aminotransferase (AST) < 5 × ULN
Aspartate aminotransferase (AST) =< 3 x ULN (must be within 7 days of MLA)
Aspartate aminotransferase (AST) =< 121 IU/L
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) > 3 x ULN
Aspartate aminotransferase (AST) < 5 x ULN
Aspartate aminotransferase (AST) < 3 times the ULN
Aspartate aminotransferase level (<=) 2.5* ULN, and
Aspartate aminotransferase (AST) within the reference range during screening evaluation
Aspartate aminotransferase (AST) > 5 x ULN
To be performed within 14 days prior to day 1 of protocol therapy: aspartate aminotransferase (AST) =< 3 x ULN\r\n* If hepatic involvement by lymphoma: AST =< 5 x ULN
Within 14 days prior to day 1 of protocol therapy unless otherwise stated: Aspartate aminotransferase (AST) =< 2 x ULN
At cycle 1 day 1 pre-dosing: Aspartate aminotransferase (AST) >= 2.5 x the ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN for the laboratory
Aspartate aminotransferase (AST) =< 3 x ULN
Aspartate aminotransferase (AST) =< 2 x ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 3 x ULN for the laboratory
Aspartate aminotransferase (AST) < 2.5 x ULN of the institutional normal reference range
Aspartate aminotransferase (AST) must be =< 1.5 x ULN for the lab
Aspartate transaminase (aspartate aminotransferase [AST]) =< 2.5 x ULN (=< 5 x ULN in patients with liver metastasis), obtained =< 21 days prior to registration
Aspartate aminotransferase (AST) ? 2.0 X ULN,
Aspartate aminotransferase (AST) ? 2 x ULN
Aspartate aminotransferase (AST) =< 3 x ULN within 14 days prior to study registration
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase less than or equal to 3 x ULN
Aspartate aminotransferase (AST) =< 3 x ULN
Aspartate aminotransferase (AST) < 5 x ULN
Aspartate aminotransferase (AST) =< 3 x ULN
Aspartate aminotransferase (AST) =< 1.5 X ULN
and aspartate aminotransferase (AST) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases
Aspartate aminotransferase (AST) ? 1.5 x ULN unless there is hepatic involvement, then 3 x ULN
Aspartate aminotransferase (AST) =< 5 x ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 3 X ULN
Aspartate aminotransferase (AST) =< 1.5 x ULN
Aspartate aminotransferase (AST) =< 3 x ULN
Aspartate aminotransferase (AST) =< 3 x ULN
Aspartate aminotransferase (AST) =< 2.5 x the ULN for age (in the absence of hepatic involvement of tumor)
Aspartate aminotransferase (AST) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases
Aspartate aminotransferase > 100 IU/L
Aspartate aminotransferase (AST) ?3 × ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) =< 1.5 X ULN
Aspartate aminotransferase (AST) =< 2.5 x the ULN (in the absence of hepatic involvement of tumor)
Aspartate aminotransferase (AST) =< 3 times ULN
Aspartate aminotransferase (AST) and ALT < 3.0 × ULN
Aspartate aminotransferase (AST) =< 3 times ULN
Aspartate aminotransferase (AST) =< 2.5 x ULN
Aspartate aminotransferase (AST) < 5 x ULN
Aspartate aminotransferase (AST) < 5.0 x ULN
Aspartate aminotransferase (AST) =< 2 x institutional ULN
Aspartate aminotransferase level (AST) =< 3 x ULN, within 30 days prior to enrollment
Obtained within 28 days prior to registration: Aspartate aminotransferase (AST) =< 2.5 x ULN (subjects with documented liver metastases should have AST =< 5 x ULN)
Aspartate aminotransferase (AST) < 3 × ULN unless hepatic metastases are present, then < 5 × ULN
Aspartate aminotransferase (AST) < 5 X institutional ULN
Aspartate aminotransferase (AST) =< 1.5 x ULN
Aspartate aminotransferase (AST) > 3 x ULN
Aspartate aminotransferase =< 45 IU/dL
